nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—BCHE—malignant glioma	0.716	1	CbGaD
Rivastigmine—CYP3A4—Temozolomide—malignant glioma	0.0786	1	CbGbCtD
Rivastigmine—Pyridostigmine—BCHE—malignant glioma	0.00345	0.569	CrCbGaD
Rivastigmine—Neostigmine—BCHE—malignant glioma	0.00261	0.431	CrCbGaD
Rivastigmine—Personality disorder—Carmustine—malignant glioma	0.00225	0.0132	CcSEcCtD
Rivastigmine—Disorder sight—Temozolomide—malignant glioma	0.00197	0.0116	CcSEcCtD
Rivastigmine—Faecal incontinence—Carmustine—malignant glioma	0.00193	0.0113	CcSEcCtD
Rivastigmine—Transient ischaemic attack—Temozolomide—malignant glioma	0.00186	0.0109	CcSEcCtD
Rivastigmine—Faecal incontinence—Temozolomide—malignant glioma	0.00186	0.0109	CcSEcCtD
Rivastigmine—Cerebration impaired—Temozolomide—malignant glioma	0.0016	0.00938	CcSEcCtD
Rivastigmine—Haemorrhoids—Temozolomide—malignant glioma	0.0016	0.00938	CcSEcCtD
Rivastigmine—Aphasia—Carmustine—malignant glioma	0.0015	0.0088	CcSEcCtD
Rivastigmine—Tooth disorder—Temozolomide—malignant glioma	0.00145	0.00851	CcSEcCtD
Rivastigmine—Aphasia—Temozolomide—malignant glioma	0.00145	0.00851	CcSEcCtD
Rivastigmine—Hypokinesia—Carmustine—malignant glioma	0.00144	0.00846	CcSEcCtD
Rivastigmine—Paranoia—Carmustine—malignant glioma	0.00143	0.00838	CcSEcCtD
Rivastigmine—Thrombosis—Carmustine—malignant glioma	0.00137	0.00807	CcSEcCtD
Rivastigmine—Lung disorder—Temozolomide—malignant glioma	0.00133	0.0078	CcSEcCtD
Rivastigmine—Apathy—Temozolomide—malignant glioma	0.00132	0.00773	CcSEcCtD
Rivastigmine—Influenza-like symptoms—Temozolomide—malignant glioma	0.00132	0.00773	CcSEcCtD
Rivastigmine—Flat affect—Temozolomide—malignant glioma	0.0013	0.00766	CcSEcCtD
Rivastigmine—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00127	0.00746	CcSEcCtD
Rivastigmine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00125	0.00733	CcSEcCtD
Rivastigmine—Herpes zoster—Temozolomide—malignant glioma	0.00125	0.00733	CcSEcCtD
Rivastigmine—Abscess—Carmustine—malignant glioma	0.00123	0.00722	CcSEcCtD
Rivastigmine—Otitis media—Temozolomide—malignant glioma	0.00121	0.00709	CcSEcCtD
Rivastigmine—Coagulopathy—Temozolomide—malignant glioma	0.00121	0.00709	CcSEcCtD
Rivastigmine—Rigors—Temozolomide—malignant glioma	0.00115	0.00676	CcSEcCtD
Rivastigmine—Speech disorder—Carmustine—malignant glioma	0.00113	0.00664	CcSEcCtD
Rivastigmine—Speech disorder—Temozolomide—malignant glioma	0.00109	0.00642	CcSEcCtD
Rivastigmine—Disturbance in attention—Temozolomide—malignant glioma	0.00108	0.00637	CcSEcCtD
Rivastigmine—Breast pain—Temozolomide—malignant glioma	0.00108	0.00632	CcSEcCtD
Rivastigmine—Viral infection—Temozolomide—malignant glioma	0.00104	0.00611	CcSEcCtD
Rivastigmine—Leukocytosis—Carmustine—malignant glioma	0.00103	0.00608	CcSEcCtD
Rivastigmine—Herpes simplex—Temozolomide—malignant glioma	0.00102	0.00599	CcSEcCtD
Rivastigmine—Gait disturbance—Carmustine—malignant glioma	0.000996	0.00585	CcSEcCtD
Rivastigmine—Coordination abnormal—Carmustine—malignant glioma	0.00099	0.00581	CcSEcCtD
Rivastigmine—Pulmonary embolism—Carmustine—malignant glioma	0.000972	0.00571	CcSEcCtD
Rivastigmine—Gait disturbance—Temozolomide—malignant glioma	0.000963	0.00565	CcSEcCtD
Rivastigmine—Respiratory failure—Temozolomide—malignant glioma	0.000957	0.00562	CcSEcCtD
Rivastigmine—Coordination abnormal—Temozolomide—malignant glioma	0.000957	0.00562	CcSEcCtD
Rivastigmine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00094	0.00552	CcSEcCtD
Rivastigmine—Vaginal inflammation—Temozolomide—malignant glioma	0.00094	0.00552	CcSEcCtD
Rivastigmine—Pulmonary embolism—Temozolomide—malignant glioma	0.00094	0.00552	CcSEcCtD
Rivastigmine—Urinary incontinence—Carmustine—malignant glioma	0.000939	0.00551	CcSEcCtD
Rivastigmine—Skin exfoliation—Carmustine—malignant glioma	0.000928	0.00545	CcSEcCtD
Rivastigmine—Candida infection—Carmustine—malignant glioma	0.000928	0.00545	CcSEcCtD
Rivastigmine—Neuropathy—Carmustine—malignant glioma	0.000913	0.00536	CcSEcCtD
Rivastigmine—Influenza like illness—Temozolomide—malignant glioma	0.000913	0.00536	CcSEcCtD
Rivastigmine—Urinary incontinence—Temozolomide—malignant glioma	0.000907	0.00533	CcSEcCtD
Rivastigmine—Candida infection—Temozolomide—malignant glioma	0.000897	0.00527	CcSEcCtD
Rivastigmine—Skin exfoliation—Temozolomide—malignant glioma	0.000897	0.00527	CcSEcCtD
Rivastigmine—Coma—Carmustine—malignant glioma	0.000888	0.00522	CcSEcCtD
Rivastigmine—Vaginal infection—Temozolomide—malignant glioma	0.000887	0.00521	CcSEcCtD
Rivastigmine—Neuropathy—Temozolomide—malignant glioma	0.000882	0.00518	CcSEcCtD
Rivastigmine—Neoplasm—Carmustine—malignant glioma	0.000879	0.00516	CcSEcCtD
Rivastigmine—Neoplasm—Temozolomide—malignant glioma	0.00085	0.00499	CcSEcCtD
Rivastigmine—Abnormal vision—Carmustine—malignant glioma	0.000848	0.00498	CcSEcCtD
Rivastigmine—Sepsis—Carmustine—malignant glioma	0.000844	0.00496	CcSEcCtD
Rivastigmine—Mental disability—Carmustine—malignant glioma	0.000844	0.00496	CcSEcCtD
Rivastigmine—Abnormal vision—Temozolomide—malignant glioma	0.000819	0.00481	CcSEcCtD
Rivastigmine—Phlebitis—Carmustine—malignant glioma	0.000819	0.00481	CcSEcCtD
Rivastigmine—Mental disability—Temozolomide—malignant glioma	0.000815	0.00479	CcSEcCtD
Rivastigmine—Thrombophlebitis—Carmustine—malignant glioma	0.000815	0.00479	CcSEcCtD
Rivastigmine—Diabetes mellitus—Carmustine—malignant glioma	0.000811	0.00477	CcSEcCtD
Rivastigmine—Ear pain—Temozolomide—malignant glioma	0.000799	0.00469	CcSEcCtD
Rivastigmine—Thrombophlebitis—Temozolomide—malignant glioma	0.000788	0.00463	CcSEcCtD
Rivastigmine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000784	0.00461	CcSEcCtD
Rivastigmine—Eye pain—Carmustine—malignant glioma	0.000782	0.00459	CcSEcCtD
Rivastigmine—Gastroenteritis—Temozolomide—malignant glioma	0.00077	0.00452	CcSEcCtD
Rivastigmine—Injury—Carmustine—malignant glioma	0.000768	0.00451	CcSEcCtD
Rivastigmine—Vascular purpura—Temozolomide—malignant glioma	0.000762	0.00448	CcSEcCtD
Rivastigmine—Deafness—Temozolomide—malignant glioma	0.000762	0.00448	CcSEcCtD
Rivastigmine—Eye pain—Temozolomide—malignant glioma	0.000756	0.00444	CcSEcCtD
Rivastigmine—Amnesia—Carmustine—malignant glioma	0.000751	0.00441	CcSEcCtD
Rivastigmine—Hot flush—Temozolomide—malignant glioma	0.000729	0.00428	CcSEcCtD
Rivastigmine—Amnesia—Temozolomide—malignant glioma	0.000726	0.00426	CcSEcCtD
Rivastigmine—Menopausal symptoms—Temozolomide—malignant glioma	0.000723	0.00425	CcSEcCtD
Rivastigmine—Thirst—Temozolomide—malignant glioma	0.000717	0.00421	CcSEcCtD
Rivastigmine—Hyponatraemia—Carmustine—malignant glioma	0.000709	0.00416	CcSEcCtD
Rivastigmine—Purpura—Temozolomide—malignant glioma	0.000708	0.00416	CcSEcCtD
Rivastigmine—Diplopia—Carmustine—malignant glioma	0.000706	0.00415	CcSEcCtD
Rivastigmine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000706	0.00415	CcSEcCtD
Rivastigmine—Diplopia—Temozolomide—malignant glioma	0.000682	0.00401	CcSEcCtD
Rivastigmine—Face oedema—Carmustine—malignant glioma	0.000681	0.004	CcSEcCtD
Rivastigmine—Affect lability—Temozolomide—malignant glioma	0.000671	0.00394	CcSEcCtD
Rivastigmine—Ataxia—Carmustine—malignant glioma	0.000664	0.0039	CcSEcCtD
Rivastigmine—Face oedema—Temozolomide—malignant glioma	0.000658	0.00387	CcSEcCtD
Rivastigmine—Liver function test abnormal—Carmustine—malignant glioma	0.000652	0.00383	CcSEcCtD
Rivastigmine—Mood swings—Temozolomide—malignant glioma	0.000646	0.00379	CcSEcCtD
Rivastigmine—Hypokalaemia—Carmustine—malignant glioma	0.000642	0.00377	CcSEcCtD
Rivastigmine—Ataxia—Temozolomide—malignant glioma	0.000641	0.00377	CcSEcCtD
Rivastigmine—Dehydration—Temozolomide—malignant glioma	0.000634	0.00373	CcSEcCtD
Rivastigmine—Dry skin—Temozolomide—malignant glioma	0.000625	0.00367	CcSEcCtD
Rivastigmine—Muscular weakness—Carmustine—malignant glioma	0.000623	0.00366	CcSEcCtD
Rivastigmine—Hypokalaemia—Temozolomide—malignant glioma	0.000621	0.00365	CcSEcCtD
Rivastigmine—Breast disorder—Temozolomide—malignant glioma	0.000616	0.00362	CcSEcCtD
Rivastigmine—Dysphagia—Carmustine—malignant glioma	0.00061	0.00358	CcSEcCtD
Rivastigmine—Muscular weakness—Temozolomide—malignant glioma	0.000602	0.00353	CcSEcCtD
Rivastigmine—Dysphagia—Temozolomide—malignant glioma	0.00059	0.00346	CcSEcCtD
Rivastigmine—Sweating increased—Temozolomide—malignant glioma	0.000574	0.00337	CcSEcCtD
Rivastigmine—Bronchitis—Temozolomide—malignant glioma	0.000567	0.00333	CcSEcCtD
Rivastigmine—Dysuria—Temozolomide—malignant glioma	0.000551	0.00324	CcSEcCtD
Rivastigmine—Hyperglycaemia—Carmustine—malignant glioma	0.00055	0.00323	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000548	0.00322	CcSEcCtD
Rivastigmine—Pneumonia—Carmustine—malignant glioma	0.000547	0.00321	CcSEcCtD
Rivastigmine—Pollakiuria—Temozolomide—malignant glioma	0.000545	0.0032	CcSEcCtD
Rivastigmine—Erectile dysfunction—Temozolomide—malignant glioma	0.000543	0.00319	CcSEcCtD
Rivastigmine—Depression—Carmustine—malignant glioma	0.000542	0.00319	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000538	0.00316	CcSEcCtD
Rivastigmine—Weight increased—Temozolomide—malignant glioma	0.000536	0.00315	CcSEcCtD
Rivastigmine—Renal failure—Carmustine—malignant glioma	0.000535	0.00314	CcSEcCtD
Rivastigmine—Weight decreased—Temozolomide—malignant glioma	0.000533	0.00313	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Carmustine—malignant glioma	0.000533	0.00313	CcSEcCtD
Rivastigmine—Hyperglycaemia—Temozolomide—malignant glioma	0.000532	0.00312	CcSEcCtD
Rivastigmine—Urinary tract infection—Carmustine—malignant glioma	0.000529	0.0031	CcSEcCtD
Rivastigmine—Pneumonia—Temozolomide—malignant glioma	0.000529	0.0031	CcSEcCtD
Rivastigmine—Infestation NOS—Temozolomide—malignant glioma	0.000526	0.00309	CcSEcCtD
Rivastigmine—Infestation—Temozolomide—malignant glioma	0.000526	0.00309	CcSEcCtD
Rivastigmine—Depression—Temozolomide—malignant glioma	0.000524	0.00308	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000521	0.00306	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000515	0.00303	CcSEcCtD
Rivastigmine—BCHE—Irinotecan Pathway—APC—malignant glioma	0.000511	0.0176	CbGpPWpGaD
Rivastigmine—Urinary tract infection—Temozolomide—malignant glioma	0.000511	0.003	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Temozolomide—malignant glioma	0.000497	0.00292	CcSEcCtD
Rivastigmine—Sinusitis—Temozolomide—malignant glioma	0.000493	0.0029	CcSEcCtD
Rivastigmine—Haemoglobin—Carmustine—malignant glioma	0.000491	0.00288	CcSEcCtD
Rivastigmine—Haemorrhage—Carmustine—malignant glioma	0.000488	0.00287	CcSEcCtD
Rivastigmine—Hallucination—Carmustine—malignant glioma	0.000486	0.00285	CcSEcCtD
Rivastigmine—Hypoaesthesia—Carmustine—malignant glioma	0.000486	0.00285	CcSEcCtD
Rivastigmine—Oedema peripheral—Carmustine—malignant glioma	0.000481	0.00282	CcSEcCtD
Rivastigmine—Connective tissue disorder—Carmustine—malignant glioma	0.00048	0.00282	CcSEcCtD
Rivastigmine—Haemoglobin—Temozolomide—malignant glioma	0.000474	0.00279	CcSEcCtD
Rivastigmine—ACHE—ATF-2 transcription factor network—NF1—malignant glioma	0.000474	0.0163	CbGpPWpGaD
Rivastigmine—Haemorrhage—Temozolomide—malignant glioma	0.000472	0.00277	CcSEcCtD
Rivastigmine—Hepatitis—Temozolomide—malignant glioma	0.000472	0.00277	CcSEcCtD
Rivastigmine—Visual impairment—Carmustine—malignant glioma	0.000471	0.00276	CcSEcCtD
Rivastigmine—Hallucination—Temozolomide—malignant glioma	0.000469	0.00276	CcSEcCtD
Rivastigmine—Hypoaesthesia—Temozolomide—malignant glioma	0.000469	0.00276	CcSEcCtD
Rivastigmine—Pharyngitis—Temozolomide—malignant glioma	0.000468	0.00275	CcSEcCtD
Rivastigmine—Urinary tract disorder—Temozolomide—malignant glioma	0.000466	0.00274	CcSEcCtD
Rivastigmine—Oedema peripheral—Temozolomide—malignant glioma	0.000465	0.00273	CcSEcCtD
Rivastigmine—Connective tissue disorder—Temozolomide—malignant glioma	0.000464	0.00272	CcSEcCtD
Rivastigmine—Urethral disorder—Temozolomide—malignant glioma	0.000463	0.00272	CcSEcCtD
Rivastigmine—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.000462	0.0159	CbGpPWpGaD
Rivastigmine—Eye disorder—Carmustine—malignant glioma	0.000456	0.00268	CcSEcCtD
Rivastigmine—Visual impairment—Temozolomide—malignant glioma	0.000455	0.00267	CcSEcCtD
Rivastigmine—Flushing—Carmustine—malignant glioma	0.000453	0.00266	CcSEcCtD
Rivastigmine—Erythema multiforme—Temozolomide—malignant glioma	0.000446	0.00262	CcSEcCtD
Rivastigmine—Eye disorder—Temozolomide—malignant glioma	0.000441	0.00259	CcSEcCtD
Rivastigmine—Tinnitus—Temozolomide—malignant glioma	0.00044	0.00258	CcSEcCtD
Rivastigmine—Flushing—Temozolomide—malignant glioma	0.000438	0.00257	CcSEcCtD
Rivastigmine—Cardiac disorder—Temozolomide—malignant glioma	0.000438	0.00257	CcSEcCtD
Rivastigmine—Arrhythmia—Carmustine—malignant glioma	0.000436	0.00256	CcSEcCtD
Rivastigmine—Alopecia—Carmustine—malignant glioma	0.000431	0.00253	CcSEcCtD
Rivastigmine—Angiopathy—Temozolomide—malignant glioma	0.000428	0.00251	CcSEcCtD
Rivastigmine—Mental disorder—Carmustine—malignant glioma	0.000428	0.00251	CcSEcCtD
Rivastigmine—Mediastinal disorder—Temozolomide—malignant glioma	0.000425	0.0025	CcSEcCtD
Rivastigmine—Malnutrition—Carmustine—malignant glioma	0.000425	0.0025	CcSEcCtD
Rivastigmine—Erythema—Carmustine—malignant glioma	0.000425	0.0025	CcSEcCtD
Rivastigmine—Chills—Temozolomide—malignant glioma	0.000423	0.00249	CcSEcCtD
Rivastigmine—Alopecia—Temozolomide—malignant glioma	0.000417	0.00245	CcSEcCtD
Rivastigmine—Mental disorder—Temozolomide—malignant glioma	0.000413	0.00243	CcSEcCtD
Rivastigmine—Back pain—Carmustine—malignant glioma	0.000411	0.00241	CcSEcCtD
Rivastigmine—Erythema—Temozolomide—malignant glioma	0.000411	0.00241	CcSEcCtD
Rivastigmine—Malnutrition—Temozolomide—malignant glioma	0.000411	0.00241	CcSEcCtD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00041	0.0141	CbGpPWpGaD
Rivastigmine—Dysgeusia—Temozolomide—malignant glioma	0.000402	0.00236	CcSEcCtD
Rivastigmine—Vision blurred—Carmustine—malignant glioma	0.000401	0.00235	CcSEcCtD
Rivastigmine—Tremor—Carmustine—malignant glioma	0.000398	0.00234	CcSEcCtD
Rivastigmine—Back pain—Temozolomide—malignant glioma	0.000397	0.00233	CcSEcCtD
Rivastigmine—Anaemia—Carmustine—malignant glioma	0.000393	0.00231	CcSEcCtD
Rivastigmine—Agitation—Carmustine—malignant glioma	0.000391	0.00229	CcSEcCtD
Rivastigmine—Vision blurred—Temozolomide—malignant glioma	0.000387	0.00227	CcSEcCtD
Rivastigmine—Tremor—Temozolomide—malignant glioma	0.000385	0.00226	CcSEcCtD
Rivastigmine—Ill-defined disorder—Temozolomide—malignant glioma	0.000381	0.00224	CcSEcCtD
Rivastigmine—Anaemia—Temozolomide—malignant glioma	0.00038	0.00223	CcSEcCtD
Rivastigmine—Agitation—Temozolomide—malignant glioma	0.000377	0.00222	CcSEcCtD
Rivastigmine—Malaise—Temozolomide—malignant glioma	0.00037	0.00218	CcSEcCtD
Rivastigmine—Vertigo—Temozolomide—malignant glioma	0.000369	0.00217	CcSEcCtD
Rivastigmine—Convulsion—Carmustine—malignant glioma	0.000368	0.00216	CcSEcCtD
Rivastigmine—Hypertension—Carmustine—malignant glioma	0.000367	0.00216	CcSEcCtD
Rivastigmine—Palpitations—Temozolomide—malignant glioma	0.000363	0.00213	CcSEcCtD
Rivastigmine—Chest pain—Carmustine—malignant glioma	0.000362	0.00213	CcSEcCtD
Rivastigmine—Myalgia—Carmustine—malignant glioma	0.000362	0.00213	CcSEcCtD
Rivastigmine—Anxiety—Carmustine—malignant glioma	0.000361	0.00212	CcSEcCtD
Rivastigmine—Cough—Temozolomide—malignant glioma	0.000358	0.00211	CcSEcCtD
Rivastigmine—Convulsion—Temozolomide—malignant glioma	0.000356	0.00209	CcSEcCtD
Rivastigmine—Hypertension—Temozolomide—malignant glioma	0.000355	0.00208	CcSEcCtD
Rivastigmine—Confusional state—Carmustine—malignant glioma	0.00035	0.00205	CcSEcCtD
Rivastigmine—Arthralgia—Temozolomide—malignant glioma	0.00035	0.00205	CcSEcCtD
Rivastigmine—Myalgia—Temozolomide—malignant glioma	0.00035	0.00205	CcSEcCtD
Rivastigmine—Anxiety—Temozolomide—malignant glioma	0.000348	0.00205	CcSEcCtD
Rivastigmine—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000348	0.012	CbGpPWpGaD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000347	0.00204	CcSEcCtD
Rivastigmine—Oedema—Carmustine—malignant glioma	0.000347	0.00204	CcSEcCtD
Rivastigmine—Discomfort—Temozolomide—malignant glioma	0.000346	0.00203	CcSEcCtD
Rivastigmine—Infection—Carmustine—malignant glioma	0.000345	0.00202	CcSEcCtD
Rivastigmine—Dry mouth—Temozolomide—malignant glioma	0.000342	0.00201	CcSEcCtD
Rivastigmine—Thrombocytopenia—Carmustine—malignant glioma	0.00034	0.00199	CcSEcCtD
Rivastigmine—Tachycardia—Carmustine—malignant glioma	0.000339	0.00199	CcSEcCtD
Rivastigmine—Confusional state—Temozolomide—malignant glioma	0.000338	0.00199	CcSEcCtD
Rivastigmine—Oedema—Temozolomide—malignant glioma	0.000335	0.00197	CcSEcCtD
Rivastigmine—Infection—Temozolomide—malignant glioma	0.000333	0.00196	CcSEcCtD
Rivastigmine—Anorexia—Carmustine—malignant glioma	0.000331	0.00194	CcSEcCtD
Rivastigmine—Nervous system disorder—Temozolomide—malignant glioma	0.000329	0.00193	CcSEcCtD
Rivastigmine—Thrombocytopenia—Temozolomide—malignant glioma	0.000328	0.00193	CcSEcCtD
Rivastigmine—Skin disorder—Temozolomide—malignant glioma	0.000326	0.00191	CcSEcCtD
Rivastigmine—Hypotension—Carmustine—malignant glioma	0.000324	0.0019	CcSEcCtD
Rivastigmine—Hyperhidrosis—Temozolomide—malignant glioma	0.000324	0.0019	CcSEcCtD
Rivastigmine—Anorexia—Temozolomide—malignant glioma	0.00032	0.00188	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000316	0.00186	CcSEcCtD
Rivastigmine—Insomnia—Carmustine—malignant glioma	0.000314	0.00184	CcSEcCtD
Rivastigmine—Paraesthesia—Carmustine—malignant glioma	0.000311	0.00183	CcSEcCtD
Rivastigmine—Dyspnoea—Carmustine—malignant glioma	0.000309	0.00182	CcSEcCtD
Rivastigmine—Somnolence—Carmustine—malignant glioma	0.000308	0.00181	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000305	0.00179	CcSEcCtD
Rivastigmine—Insomnia—Temozolomide—malignant glioma	0.000303	0.00178	CcSEcCtD
Rivastigmine—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000302	0.0104	CbGpPWpGaD
Rivastigmine—Decreased appetite—Carmustine—malignant glioma	0.000302	0.00177	CcSEcCtD
Rivastigmine—Paraesthesia—Temozolomide—malignant glioma	0.000301	0.00177	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000299	0.00176	CcSEcCtD
Rivastigmine—Dyspnoea—Temozolomide—malignant glioma	0.000299	0.00176	CcSEcCtD
Rivastigmine—Somnolence—Temozolomide—malignant glioma	0.000298	0.00175	CcSEcCtD
Rivastigmine—Pain—Carmustine—malignant glioma	0.000297	0.00174	CcSEcCtD
Rivastigmine—Constipation—Carmustine—malignant glioma	0.000297	0.00174	CcSEcCtD
Rivastigmine—Dyspepsia—Temozolomide—malignant glioma	0.000295	0.00173	CcSEcCtD
Rivastigmine—Decreased appetite—Temozolomide—malignant glioma	0.000291	0.00171	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000289	0.0017	CcSEcCtD
Rivastigmine—Fatigue—Temozolomide—malignant glioma	0.000289	0.0017	CcSEcCtD
Rivastigmine—Constipation—Temozolomide—malignant glioma	0.000287	0.00168	CcSEcCtD
Rivastigmine—Pain—Temozolomide—malignant glioma	0.000287	0.00168	CcSEcCtD
Rivastigmine—Feeling abnormal—Carmustine—malignant glioma	0.000286	0.00168	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Carmustine—malignant glioma	0.000284	0.00167	CcSEcCtD
Rivastigmine—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000283	0.00974	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Temozolomide—malignant glioma	0.000276	0.00162	CcSEcCtD
Rivastigmine—Abdominal pain—Carmustine—malignant glioma	0.000274	0.00161	CcSEcCtD
Rivastigmine—Body temperature increased—Carmustine—malignant glioma	0.000274	0.00161	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000274	0.00161	CcSEcCtD
Rivastigmine—Urticaria—Temozolomide—malignant glioma	0.000266	0.00156	CcSEcCtD
Rivastigmine—Body temperature increased—Temozolomide—malignant glioma	0.000265	0.00156	CcSEcCtD
Rivastigmine—Abdominal pain—Temozolomide—malignant glioma	0.000265	0.00156	CcSEcCtD
Rivastigmine—Hypersensitivity—Carmustine—malignant glioma	0.000256	0.0015	CcSEcCtD
Rivastigmine—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000251	0.00864	CbGpPWpGaD
Rivastigmine—ACHE—Peptide hormone metabolism—BCHE—malignant glioma	0.000249	0.00858	CbGpPWpGaD
Rivastigmine—Asthenia—Carmustine—malignant glioma	0.000249	0.00146	CcSEcCtD
Rivastigmine—Hypersensitivity—Temozolomide—malignant glioma	0.000247	0.00145	CcSEcCtD
Rivastigmine—ACHE—ATF-2 transcription factor network—HES1—malignant glioma	0.000245	0.00845	CbGpPWpGaD
Rivastigmine—ACHE—Glycerophospholipid biosynthesis—BCHE—malignant glioma	0.000242	0.00835	CbGpPWpGaD
Rivastigmine—Asthenia—Temozolomide—malignant glioma	0.000241	0.00141	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00024	0.00825	CbGpPWpGaD
Rivastigmine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000239	0.00823	CbGpPWpGaD
Rivastigmine—Diarrhoea—Carmustine—malignant glioma	0.000237	0.00139	CcSEcCtD
Rivastigmine—Pruritus—Temozolomide—malignant glioma	0.000237	0.00139	CcSEcCtD
Rivastigmine—ACHE—ATF-2 transcription factor network—PDGFRA—malignant glioma	0.000234	0.00805	CbGpPWpGaD
Rivastigmine—Dizziness—Carmustine—malignant glioma	0.000229	0.00135	CcSEcCtD
Rivastigmine—Diarrhoea—Temozolomide—malignant glioma	0.000229	0.00135	CcSEcCtD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000228	0.00784	CbGpPWpGaD
Rivastigmine—Dizziness—Temozolomide—malignant glioma	0.000222	0.0013	CcSEcCtD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000221	0.00761	CbGpPWpGaD
Rivastigmine—Vomiting—Carmustine—malignant glioma	0.000221	0.0013	CcSEcCtD
Rivastigmine—Rash—Carmustine—malignant glioma	0.000219	0.00128	CcSEcCtD
Rivastigmine—Dermatitis—Carmustine—malignant glioma	0.000219	0.00128	CcSEcCtD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000218	0.00751	CbGpPWpGaD
Rivastigmine—Headache—Carmustine—malignant glioma	0.000217	0.00128	CcSEcCtD
Rivastigmine—Vomiting—Temozolomide—malignant glioma	0.000213	0.00125	CcSEcCtD
Rivastigmine—Rash—Temozolomide—malignant glioma	0.000211	0.00124	CcSEcCtD
Rivastigmine—Dermatitis—Temozolomide—malignant glioma	0.000211	0.00124	CcSEcCtD
Rivastigmine—Headache—Temozolomide—malignant glioma	0.00021	0.00123	CcSEcCtD
Rivastigmine—ACHE—Monoamine Transport—IL1B—malignant glioma	0.000209	0.00719	CbGpPWpGaD
Rivastigmine—Nausea—Carmustine—malignant glioma	0.000206	0.00121	CcSEcCtD
Rivastigmine—Nausea—Temozolomide—malignant glioma	0.000199	0.00117	CcSEcCtD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000192	0.0066	CbGpPWpGaD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000189	0.00652	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000182	0.00625	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000179	0.00617	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000172	0.00593	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—BCHE—malignant glioma	0.000169	0.00582	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—MMP2—malignant glioma	0.000161	0.00553	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000155	0.00535	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000155	0.00534	CbGpPWpGaD
Rivastigmine—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000154	0.00529	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000153	0.00528	CbGpPWpGaD
Rivastigmine—ACHE—Monoamine Transport—TNF—malignant glioma	0.000152	0.00522	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—BCL2—malignant glioma	0.000145	0.00499	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000145	0.00498	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—IFNG—malignant glioma	0.000144	0.00494	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000143	0.00491	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00014	0.00483	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—CXCL8—malignant glioma	0.000133	0.00459	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000126	0.00433	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000125	0.00432	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000124	0.00426	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000118	0.00407	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000118	0.00406	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000117	0.00404	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—RTEL1—malignant glioma	0.000114	0.00393	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000109	0.00376	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000105	0.00363	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—RTEL1—malignant glioma	0.000102	0.0035	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000102	0.0035	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000101	0.00349	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000101	0.00346	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—BCHE—malignant glioma	9.63e-05	0.00332	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	9.52e-05	0.00328	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	9.39e-05	0.00323	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—XBP1—malignant glioma	9.19e-05	0.00317	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CG—malignant glioma	9.18e-05	0.00316	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	9.13e-05	0.00314	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—SLC6A3—malignant glioma	9.06e-05	0.00312	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	8.46e-05	0.00291	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	8.26e-05	0.00284	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—XBP1—malignant glioma	8.2e-05	0.00282	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CG—malignant glioma	8.19e-05	0.00282	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	8.16e-05	0.00281	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.15e-05	0.00281	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	8.14e-05	0.0028	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—SLC6A3—malignant glioma	8.08e-05	0.00278	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CD—malignant glioma	8.07e-05	0.00278	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.89e-05	0.00272	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	7.7e-05	0.00265	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	7.31e-05	0.00252	CbGpPWpGaD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	7.29e-05	0.00251	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.27e-05	0.0025	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CD—malignant glioma	7.2e-05	0.00248	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	7.08e-05	0.00244	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.04e-05	0.00242	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CB—malignant glioma	7.04e-05	0.00242	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	7e-05	0.00241	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—SPHK1—malignant glioma	6.82e-05	0.00235	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTT1—malignant glioma	6.68e-05	0.0023	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—COX8A—malignant glioma	6.55e-05	0.00226	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—BRAF—malignant glioma	6.42e-05	0.00221	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CB—malignant glioma	6.28e-05	0.00216	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—PTGS1—malignant glioma	6.26e-05	0.00215	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	6.23e-05	0.00214	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	6.14e-05	0.00211	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—SPHK1—malignant glioma	6.08e-05	0.00209	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PTEN—malignant glioma	6.08e-05	0.00209	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.96e-05	0.00205	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.86e-05	0.00202	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—COX8A—malignant glioma	5.85e-05	0.00201	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—BRAF—malignant glioma	5.72e-05	0.00197	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5.66e-05	0.00195	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	5.58e-05	0.00192	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ASMT—malignant glioma	5.57e-05	0.00192	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.56e-05	0.00191	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	5.5e-05	0.00189	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.45e-05	0.00188	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PTEN—malignant glioma	5.42e-05	0.00187	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	5.4e-05	0.00186	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	5.38e-05	0.00185	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—MDM2—malignant glioma	5.38e-05	0.00185	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—RAF1—malignant glioma	5.36e-05	0.00184	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	5.32e-05	0.00183	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—BCAN—malignant glioma	5.24e-05	0.0018	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.23e-05	0.0018	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.99e-05	0.00172	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ASMT—malignant glioma	4.97e-05	0.00171	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—BRAF—malignant glioma	4.92e-05	0.00169	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—MDM2—malignant glioma	4.8e-05	0.00165	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—RAF1—malignant glioma	4.78e-05	0.00165	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—BCHE—malignant glioma	4.71e-05	0.00162	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.69e-05	0.00161	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—RTEL1—malignant glioma	4.68e-05	0.00161	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—BCAN—malignant glioma	4.67e-05	0.00161	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	4.67e-05	0.00161	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—FBXW7—malignant glioma	4.63e-05	0.00159	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	4.63e-05	0.00159	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	4.57e-05	0.00157	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—BRAF—malignant glioma	4.39e-05	0.00151	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	4.37e-05	0.0015	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CA—malignant glioma	4.29e-05	0.00148	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.23e-05	0.00146	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—IDH2—malignant glioma	4.22e-05	0.00145	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—FBXW7—malignant glioma	4.13e-05	0.00142	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—MDM2—malignant glioma	4.12e-05	0.00142	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—RAF1—malignant glioma	4.1e-05	0.00141	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.09e-05	0.00141	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.98e-05	0.00137	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP2B6—malignant glioma	3.97e-05	0.00137	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.9e-05	0.00134	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CA—malignant glioma	3.83e-05	0.00132	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.81e-05	0.00131	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—IDH2—malignant glioma	3.77e-05	0.0013	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—MDM2—malignant glioma	3.67e-05	0.00127	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—RAF1—malignant glioma	3.66e-05	0.00126	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—IDH1—malignant glioma	3.63e-05	0.00125	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.63e-05	0.00125	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.6e-05	0.00124	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.55e-05	0.00122	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2B6—malignant glioma	3.54e-05	0.00122	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SPHK1—malignant glioma	3.51e-05	0.00121	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP2C18—malignant glioma	3.44e-05	0.00119	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.31e-05	0.00114	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.25e-05	0.00112	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—IDH1—malignant glioma	3.24e-05	0.00112	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.2e-05	0.0011	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SPHK1—malignant glioma	3.13e-05	0.00108	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2C18—malignant glioma	3.07e-05	0.00106	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—RTEL1—malignant glioma	3.06e-05	0.00105	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.03e-05	0.00104	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	2.98e-05	0.00103	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.96e-05	0.00102	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.9e-05	0.000997	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.85e-05	0.000983	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTT1—malignant glioma	2.78e-05	0.000959	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.7e-05	0.00093	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—COX8A—malignant glioma	2.69e-05	0.000926	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—F2—malignant glioma	2.67e-05	0.000919	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.64e-05	0.000908	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS1—malignant glioma	2.61e-05	0.000898	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.6e-05	0.000895	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.55e-05	0.000877	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTT1—malignant glioma	2.48e-05	0.000855	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—BCHE—malignant glioma	2.43e-05	0.000835	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SLC5A5—malignant glioma	2.4e-05	0.000825	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—F2—malignant glioma	2.38e-05	0.00082	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS1—malignant glioma	2.33e-05	0.000801	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.32e-05	0.000798	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ASMT—malignant glioma	2.29e-05	0.000787	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.27e-05	0.00078	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—MMP2—malignant glioma	2.26e-05	0.00078	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.24e-05	0.000773	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—BCAN—malignant glioma	2.15e-05	0.00074	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC5A5—malignant glioma	2.14e-05	0.000736	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.02e-05	0.000696	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—MMP2—malignant glioma	2.02e-05	0.000695	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2e-05	0.00069	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.96e-05	0.000674	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTP1—malignant glioma	1.93e-05	0.000664	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CXCL8—malignant glioma	1.88e-05	0.000648	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CAT—malignant glioma	1.88e-05	0.000647	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NCOR1—malignant glioma	1.77e-05	0.000611	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—COX8A—malignant glioma	1.76e-05	0.000605	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.75e-05	0.000601	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—IDH2—malignant glioma	1.73e-05	0.000596	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTP1—malignant glioma	1.72e-05	0.000593	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CXCL8—malignant glioma	1.68e-05	0.000578	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CAT—malignant glioma	1.68e-05	0.000577	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.63e-05	0.000561	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NCOR1—malignant glioma	1.58e-05	0.000545	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ASMT—malignant glioma	1.49e-05	0.000515	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—IDH1—malignant glioma	1.49e-05	0.000513	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CAV1—malignant glioma	1.45e-05	0.000498	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.44e-05	0.000496	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.41e-05	0.000486	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—BCAN—malignant glioma	1.4e-05	0.000484	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.38e-05	0.000476	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CG—malignant glioma	1.32e-05	0.000453	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CAV1—malignant glioma	1.29e-05	0.000444	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PPARG—malignant glioma	1.27e-05	0.000438	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.23e-05	0.000424	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CG—malignant glioma	1.17e-05	0.000404	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CD—malignant glioma	1.16e-05	0.000399	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.14e-05	0.000393	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PPARG—malignant glioma	1.13e-05	0.00039	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—IDH2—malignant glioma	1.13e-05	0.00039	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS1—malignant glioma	1.07e-05	0.000368	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.06e-05	0.000367	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CD—malignant glioma	1.03e-05	0.000356	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CB—malignant glioma	1.01e-05	0.000347	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS2—malignant glioma	1e-05	0.000344	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—BCHE—malignant glioma	9.95e-06	0.000343	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC5A5—malignant glioma	9.83e-06	0.000338	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—IDH1—malignant glioma	9.74e-06	0.000335	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SPHK1—malignant glioma	9.42e-06	0.000324	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.23e-06	0.000318	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CB—malignant glioma	9e-06	0.00031	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS2—malignant glioma	8.92e-06	0.000307	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTEN—malignant glioma	8.72e-06	0.0003	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTP1—malignant glioma	7.92e-06	0.000273	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTEN—malignant glioma	7.78e-06	0.000268	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CAT—malignant glioma	7.7e-06	0.000265	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTT1—malignant glioma	7.47e-06	0.000257	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NCOR1—malignant glioma	7.27e-06	0.00025	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS1—malignant glioma	7e-06	0.000241	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—BCHE—malignant glioma	6.5e-06	0.000224	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.42e-06	0.000221	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CA—malignant glioma	6.15e-06	0.000212	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CAV1—malignant glioma	5.93e-06	0.000204	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CA—malignant glioma	5.49e-06	0.000189	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.4e-06	0.000186	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPARG—malignant glioma	5.21e-06	0.000179	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTP1—malignant glioma	5.18e-06	0.000178	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CAT—malignant glioma	5.04e-06	0.000173	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKT1—malignant glioma	5.02e-06	0.000173	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.76e-06	0.000164	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.75e-06	0.000163	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKT1—malignant glioma	4.48e-06	0.000154	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.14e-06	0.000143	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS2—malignant glioma	4.1e-06	0.000141	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CAV1—malignant glioma	3.88e-06	0.000133	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTEN—malignant glioma	3.58e-06	0.000123	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.53e-06	0.000122	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPARG—malignant glioma	3.41e-06	0.000117	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.1e-06	0.000107	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.71e-06	9.32e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.68e-06	9.23e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.52e-06	8.69e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTEN—malignant glioma	2.34e-06	8.05e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKT1—malignant glioma	2.06e-06	7.1e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.65e-06	5.68e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKT1—malignant glioma	1.35e-06	4.64e-05	CbGpPWpGaD
